Cargando…
Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270979/ https://www.ncbi.nlm.nih.gov/pubmed/32518880 http://dx.doi.org/10.1016/j.ekir.2020.03.022 |
_version_ | 1783542000718446592 |
---|---|
author | Hui, Jessica W. Banks, Mindy Nadasdy, Tibor Rovin, Brad H. Abbott, Jordan K. |
author_facet | Hui, Jessica W. Banks, Mindy Nadasdy, Tibor Rovin, Brad H. Abbott, Jordan K. |
author_sort | Hui, Jessica W. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7270979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-72709792020-06-08 Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab Hui, Jessica W. Banks, Mindy Nadasdy, Tibor Rovin, Brad H. Abbott, Jordan K. Kidney Int Rep Nephrology Round Elsevier 2020-03-30 /pmc/articles/PMC7270979/ /pubmed/32518880 http://dx.doi.org/10.1016/j.ekir.2020.03.022 Text en © 2020 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Nephrology Round Hui, Jessica W. Banks, Mindy Nadasdy, Tibor Rovin, Brad H. Abbott, Jordan K. Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab |
title | Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab |
title_full | Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab |
title_fullStr | Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab |
title_full_unstemmed | Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab |
title_short | Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab |
title_sort | use of bortezomib in the treatment of c3 glomerulonephritis refractory to eculizumab and rituximab |
topic | Nephrology Round |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270979/ https://www.ncbi.nlm.nih.gov/pubmed/32518880 http://dx.doi.org/10.1016/j.ekir.2020.03.022 |
work_keys_str_mv | AT huijessicaw useofbortezomibinthetreatmentofc3glomerulonephritisrefractorytoeculizumabandrituximab AT banksmindy useofbortezomibinthetreatmentofc3glomerulonephritisrefractorytoeculizumabandrituximab AT nadasdytibor useofbortezomibinthetreatmentofc3glomerulonephritisrefractorytoeculizumabandrituximab AT rovinbradh useofbortezomibinthetreatmentofc3glomerulonephritisrefractorytoeculizumabandrituximab AT abbottjordank useofbortezomibinthetreatmentofc3glomerulonephritisrefractorytoeculizumabandrituximab |